Editorial radiotherapy and oncology 2002: Predictive assays for normal tissue damage

Radiotherapy and Oncology

Volumn 64, Issue 2, 2002, Pages 125-129

  Russell, Nicola S ^a   Begg, Adrian C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR;

ATAXIA TELANGIECTASIA; BIOASSAY; BREAST; CANCER PATIENT; CANCER RADIOTHERAPY; CELL CYCLE; CELL TYPE; CHROMOSOME DAMAGE; COLONY FORMATION; DNA DAMAGE; EDITORIAL; HUMAN; LABORATORY; LYMPHOCYTE; MORBIDITY; OUTPATIENT DEPARTMENT; PREDICTION; PRIORITY JOURNAL; RADIATION INJURY; RADIATION RESPONSE; RADIOSENSITIVITY; SKIN; TISSUE INJURY; TISSUE REACTION; TISSUE TYPES;

DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE EXPRESSION PROFILING; HUMANS; PREDICTIVE VALUE OF TESTS; RADIATION ONCOLOGY; RADIATION TOLERANCE; RADIOTHERAPY; TUMOR STEM CELL ASSAY;

EID: 0036669225     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00189-5     Document Type: Editorial

References (59)

1. Agren A., Brahme A., Turesson I. Optimisation of uncomplicated control for head and neck tumours. Int J Radiat Oncol Biol Phys. 19:1990;1077-1085.
2. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511.
3. Appleby J.M., Barber J.B., Levine E., et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer. (76):1997;1546-1549.
4. Barber J.B., Burrill W., Spreadborough A.R., et al. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol. 55:2000;179-186.
5. Barcellos-Hoff M.H., Derynck R., Tsang M.L., Weatherbee J.A. Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest. 93:1994;892-899.
6. Bentzen S.M. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother Oncol. (43):1997;121-131.
7. Bentzen S.M., Overgaard M., Overgaard J. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur J Cancer. 29A:1993;1373-1376.
8. Bentzen S.M., Overgaard M., Thames H.D., Christensen J.J., Overgaard J. Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Biol. 56:1989;711-715.
9. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 331:1994;1286-1292.
10. Borger J.H., Kemperman H., Smitt H.S., et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys. 30:1994;1073-1081.
11. Burnet N.G., Johansen J., Turesson I., Nyman J., Peacock J.H. Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering committee of the BioMed2 European Union concerted Action Programme on the Development of Predictive tests of normal tissue response to radiation therapy. Int J Cancer. 79:1998;606-613.
12. Burnet N.G., Nyman J., Turesson I., et al. Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet. (339):1992;1570-1571.
13. Cox R., Masson W.K. Radiosensitivity in cultured human fibroblasts. Int J Radiat Biol Relat Stud Phys Chem Med. 38:1980;575-576.
14. Datta P.K., Moulder J.E., Fish B.L., Cohen E.P., Lianos E.A. TGF-beta 1 production in radiation nephropathy: role of angiotensin II. Int J Radiat Biol. 75:1999;473-479.
15. Denham J.W., Hamilton C.S., Simpson S.A., et al. Acute reaction parameters for human oropharyngeal mucosa. Radiother Oncol. (35):1995;129-137.
16. Denham J.W., Hamilton C.S., Simpson S.A., et al. Factors influencing the degree of erythematous skin reactions in humans. Radiother Oncol. 36:1995;107-120.
17. Deschavanne P.J., Debieu D., Fertil B., Malaise E.P. Re-evaluation of in vitro radiosensitivity of human fibroblasts of different genetic origins. Int J Radiat Biol Relat Stud Phys Chem Med. (50):1986;279-293.
18. Franko A.J., Sharplin J., Ghahary A., Barcellos-Hoff M.H. lmmunohistochemical localisation of transforming growth factor beta and tumour necrosis factor alpha in the lungs of fibrosis-prone and 'non-fibrosing' mice during the latent period and early phase after irradiation. Radiat Res. 147:1997;245-256.
19. Geara F.B., Peters U., Ang K.K., Wike J.L., Brock W.A. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys. 27:1993;1173-1179.
20. Geara F.B., Peters U., Ang K.K., et al. Intrinsic radiosensitivity of normal human fibroblasts and lymphocytes after high- and low-dose-rate irradiation. Cancer Res. 52:1992;6348-6352.
21. Gentner N.E., Morrison D.P., Myers D.K. Impact on radiogenic cancer risk of persons exhibiting abnormal sensitivity to ionising radiation. Health Phys. 55:1988;415-425.
22. Glicksman A.S., Chu F.C.H., Bane H.N., Nickson J.J. Quantitative and qualitative evaluation of skin erythema. Clinical study in patients on a standardised irradiation schedule. Radiology. 75:1960;411-414.
23. Green M.H., Arlett C.F., Cole J., et al. Comparative human cellular radiosensitivity: III. Gamma-radiation survival of cultured skin fibroblasts and resting T-lymphocytes from the peripheral blood of the same individual. Int J Radiat Biol. 59:1991;749-765.
24. Hall E.J., Schiff P.B., Hanks G.E., et al. A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am. 4:1998;385-389.
25. Hanlon A.L., Schultheiss T.E., Hunt M.A., et al. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys. 38:1997;59-63.
26. Haston C.K., Travis E.L. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res. (57):1997;5286-5291.
27. Herskind C., Bamberg M., Rodemann H.P. The role of cytokines in the development of normal-tissue reactions after radiotherapy. Strahlenther Onkol. 174:(Suppl. 3):1998;12-15.
28. Johnston C.J., Williams J.P., Okunieff P., Finkelstein J.N. Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families. Radiat Res. 157:2002;256-265.
29. Jung H., Beck-Bornholdt H.P., Svoboda V., Alberti W., Herrmann T. Quantification of late complications after radiation therapy. Radiother Oncol. (61):2001;233-246.
30. Kiltie A.E., Ryan A.J., Swindell R., et al. A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients. Radiother Oncol. 51:1999;55-65.
31. Kushiro J., Nakamura N., Kyoizumi S., et al. Absence of correlations between radiosensitivities of human T-lymphocytes in G0 and skin fibroblasts in log phase. Radiat Res. 122:1990;326-332.
32. Lartigau E., Saunders M.I., Dische S., Warburton M.F., Des R.C. A comparison of the late radiation changes after three schedules of radiotherapy. Radiother Oncol. 20:1991;139-148.
33. Little J.B., Nove J., Strong L.C., Nichols W.W. Survival of human diploid skin fibroblasts from normal individuals after X-irradiation. Int J Radiat Biol. 54:1988;899-910.
34. MacKay R.I., Hendry J.H. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability. Radiother Oncol. 50:1999;67-75.
35. MacKay R.I., Niemierko A., Goitein M., Hendry J.H. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother Oncol. 46:1998;215-216.
36. Norman A., Kagan A.R., Chan S.L. The importance of genetics for the optimisation of radiation therapy. A hypothesis. Am J Clin Oncol. 11:1988;84-88.
37. Overgaard M., Bentzen S.M., Christensen J.J., Madsen E.H. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol. 9:1987;1-11.
38. Paterson R. The treatment of Malignant Disease by Radium and X-rays. Edward Arnold & Co., London, 1949.
39. Peacock J., Ashton A., Bliss J., et al. Cellular radiosensitivity and complication risk after curative radiotherapy. Radiother Oncol. 55:2000;173-178.
40. Pomeroy S.L., Tamayo P., Gaasenbeek M., et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 415:2002;436-442.
41. Price E.A., Bourne S.U., Radbourne R., et al. Rare microsatellite polymorphisms in the DNA repair genes XRCC1, XRCC3 and XRCC5 associated with cancer in patients of varying radiosensitivity. Somat Cell Mol Genet. 23:1997;237-247.
42. Quarmby S., West C., Magee B., et al. Differential expression of cytokine genes in fibroblasts derived from skin biopsies of patients who developed minimal or severe normal tissue damage after radiotherapy. Radiat Res. 157:2002;243-248.
43. Rogers P.B., Plowman P.N., Harris S.J., Arlett C.F. Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol. 57:2000;143-154.
44. Russell N.S., Arlett C.F., Bartelink H., Begg A.C. Use of fluorescence in situ hybridisation to determine the relationship between chromosome aberrations and cell survival in eight human fibroblast strains. Int J Radiat Biol. 68:1995;185-196.
45. Russell N.S., Grummels A., Hart A.A., et al. Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. Int J Radiat Biol. 73:1998;661-670.
46. Russell N.S., Uara P.C., Grummels A., et al. In vitro differentiation characteristics of human skin fibroblasts: correlations with radiotherapy-induced breast fibrosis in patients. Int J Radiat Biol. 76:2000;231-240.
47. Sassi M., Jukkola A., Riekki R., et al. Type I collagen turnover and cross-linking are increased in irradiated skin of breast cancer patients. Radiother Oncol. 58:2001;317-323.
48. Skwarchuk M.W., Travis E.U. Changes in histology and fibrogenic cytokines in irradiated colorectum of two murine strains. Int J Radiat Oncol Biol Phys. 42:1998;169-178.
49. Taylor A.M., Harnden D.G., Arlett C.F., et al. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 258:1975;427-429.
50. Theuws J.C., Kwa S.L., Wagenaar A.C., et al. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol. 48:1998;33-43.
51. Tucker S.L., Geara F.B., Peters U., Brock W.A. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiother Oncol. 38:1996;103-113.
52. Tucker S.U., Turesson I., Thames H.D. Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer. 28A:1992;1783-1791.
53. Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys. 19:1990;1569-1574.
54. Turesson I., Nyman J., Holmberg E., Oden A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys. 36:1996;1065-1075.
55. van Eerde M.R., Kampinga H.H., Szabo B.G., Vujaskovic Z. Comparison of three rat strains for development of radiation-induced lung injury after hemithoracic irradiation. Radiother Oncol. 58:2001;313-316.
56. van't Veer U., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:2002;530-536.
57. Weeks D.E., Paterson M.C., Lange K., et al. Assessment of chronic gamma radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia. Radiat Res. 128:1991;90-99.
58. West C.M. Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radiol. 68:1995;827-837.
59. West C.M., Davidson S.E., Elyan S.A., et al. Uymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 51:2001;10-15.